Recent Finacing
Recent Raise
ITM Isotope Technologies Munich SE develops and manufactures targeted radionuclide diagnostics and therapeutics, supplies medical radioisotopes (e.g., n.c.a. 177Lu, 225Ac), and advances Phase III therapies and companion diagnostics.
